Dupilumab Improves Outcomes for EoG in Phase 2 Clinical Trial
11-center CEGIR network study led by Cincinnati Children's advances our understanding of eosinophilic gastritis – a rare inflammatory food allergic disease of the stomach – and potentially opens promising avenues for development of new therapeutic approaches. CINCINNATI, June 29, 2026...
11-center CEGIR network study led by Cincinnati Children's advances our understanding of eosinophilic gastritis – a rare inflammatory food allergic disease of the stomach – and potentially opens promising avenues for development of new therapeutic approaches. CINCINNATI, June 29, 2026...
Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.